MIST — Milestone Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $80.70m
- $51.06m
- $1.55m
Milestone Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-AeroVironment, Civista Bancshares, Meta
U.S. STOCKS ON THE MOVE-RTX, Performance Food, MiNK Therapeutics
Milestone Pharma tumbles on deep-discounted $52.5 mln equity raise
Brief: Milestone Pharmaceuticals Announces Pricing Of $52.5 Million Public Offering
U.S. STOCKS ON THE MOVE-Cloudfare, Karyopharm, AMC Entertainment
U.S. STOCKS ON THE MOVE-Levi Strauss, Crypto Stocks, Delta
Milestone Pharma slides after equity offering launch
Brief: Milestone Pharmaceuticals Announces Proposed Public Offering
Brief: Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™
Brief: Milestone Pharmaceuticals Submits Response To The FDA’s CRL For CARDAMYST (Etripamil) Nasal Spray For PSVT Following Type A Meeting
Milestone Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results
Milestone Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Shake Shack, SatixFy, Enova
U.S. STOCKS ON THE MOVE-Shake Shack, SatixFy, Enova
Milestone Pharma falls after TD Cowen downgrades to "hold", removes PT
U.S. STOCKS ON THE MOVE-GameStop, Oxford Industries, Wolfspeed
Milestone Pharma hits record low after FDA declines to approve heart rhythm nasal spray